Nonalcoholic steatohepatitis (NASH) is becoming a common cause of liver cirrhosis requiring liver transplantation (LT). Cardiovascular complications related to metabolic syndrome and NASH recurrence in the transplanted liver may affect the outcome of LT in these patients. We compared the outcomes of
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
โ Scribed by Srinevas K. Reddy; Jennifer L. Steel; Hui-Wei Chen; David J. DeMateo; Jon Cardinal; Jaideep Behari; Abhinav Humar; J. Wallis Marsh; David A. Geller; Allan Tsung
- Book ID
- 112097818
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 940 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We read with interest the article by Bhagat et al. 1 regarding outcomes of liver transplantation (LT) in patient with cirrhosis due to nonalcoholic steatohepatitis (NASH) versus patients with cirrhosis due to alcoholic liver disease. This retrospective study showed no statistical differences in post
The incidence of hepatocellular carcinoma (HCC) is on the rise worldwide as the most common primary hepatic malignancy. In the US approximately one half of all HCC is related to Hepatitis C virus (HCV) infection. The relationship between the primary disease and HCC recurrence after liver transplanta